Pivanex

DRUG3 trials

Sponsors

Titan Pharmaceuticals

Conditions

Carcinoma, Non-Small-Cell LungLeukemia, Lymphocytic, ChronicLymphoma, Small LymphocyticMalignant Melanoma

Phase 1

A Pilot Study of Pivanex in Patients With Malignant Melanoma

TerminatedNCT00087477

Titan PharmaceuticalsMalignant Melanoma

Start: 2004-01-31End: 2004-08-31Target: 14Updated: 2005-08-30

Phase 2

Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer

CompletedNCT00073385

Titan PharmaceuticalsCarcinoma, Non-Small-Cell Lung

Start: 2003-09-30End: 2004-10-31Target: 225Updated: 2005-08-30

A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

TerminatedNCT00083473

Titan PharmaceuticalsLeukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic

Start: 2004-05-31End: 2005-04-30Target: 28Updated: 2005-08-30